Literature DB >> 2384767

Comparison of case ascertainment by medical record linkage and cohort follow-up to determine incidence rates for transient ischemic attacks and stroke.

J P Whisnant1, L J Melton, P H Davis, W M O'Fallon, K Nishimaru, B S Schoenberg.   

Abstract

During the period 1960-1972, the medical record linkage index method provided an estimated average annual age- and sex-adjusted rate for first transient ischemic attack (TIA) of 134 per 100,000 population for those age 50 years and older. The cohort method estimate was 237 per 100,000 population (95% confidence limits (CL), 165-310). The discrepancy was due to 18 cases of TIA noted at the time of patient visits in the cohort analysis that were not identified from the medical record analysis. The cohort analysis for all strokes at age 50 years and older was not significantly different from the medical record linkage analysis. Although the cohort follow-up method provided better case ascertainment in this study, current indexing procedures provide case ascertainment equal to that of the cohort method and at less cost. No trend was found to suggest that incidence rates for TIA were decreasing in the period 1955-1979, in contrast to stroke in Rochester, Minn.

Entities:  

Mesh:

Year:  1990        PMID: 2384767     DOI: 10.1016/0895-4356(90)90239-l

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  8 in total

1.  Stroke incidence and survival in three Sicilian municipalities. Sicilian Neuro-Epidemiologic Study (SNES) Group.

Authors:  W A Rocca; A Reggio; G Savettieri; G Salemi; F Patti; F Meneghini; F Grigoletto; L Morgante; R Di Perri
Journal:  Ital J Neurol Sci       Date:  1998-12

2.  Incidence and predictors of myocardial infarction after transient ischemic attack: a population-based study.

Authors:  Joseph D Burns; Alejandro A Rabinstein; Veronique L Roger; Latha G Stead; Teresa J H Christianson; Jill M Killian; Robert D Brown
Journal:  Stroke       Date:  2011-03-24       Impact factor: 7.914

3.  Carotid atherosclerotic plaque instability and cognition determined by ultrasound-measured plaque strain in asymptomatic patients with significant stenosis.

Authors:  Robert J Dempsey; Tomy Varghese; Daren C Jackson; Xiao Wang; Nirvedh H Meshram; Carol C Mitchell; Bruce P Hermann; Sterling C Johnson; Sara E Berman; Stephanie M Wilbrand
Journal:  J Neurosurg       Date:  2017-03-10       Impact factor: 5.115

4.  Risk of cardiovascular events in patients with polycystic ovary syndrome.

Authors:  S Iftikhar; M L Collazo-Clavell; V L Roger; J St Sauver; R D Brown; S Cha; D J Rhodes
Journal:  Neth J Med       Date:  2012-03       Impact factor: 1.422

5.  Validation and refinement of the ABCD2 score: a population-based analysis.

Authors:  Amy Fothergill; Teresa J H Christianson; Robert D Brown; Alejandro A Rabinstein
Journal:  Stroke       Date:  2009-06-11       Impact factor: 7.914

6.  Hyperlipidaemia and mortality among patients hospitalised with pneumonia: retrospective cohort and propensity score matched study.

Authors:  Mohammed Yousufuddin; Umesh M Sharma; Sumit Bhagra; Mohammad Hassan Murad
Journal:  BMJ Open Respir Res       Date:  2021-03

7.  Effect of early hospital readmission and comorbid conditions on subsequent long-term mortality after transient ischemic attack.

Authors:  Mohammed Yousufuddin; Nathan Young; Lawrence Keenan; Tammy Olson; Jessica Shultz; Taylor Doyle; Eimad Ahmmad; Kogulavadanan Arumaithurai; Paul Takahashi; Mohammad Hassan Murad
Journal:  Brain Behav       Date:  2017-11-22       Impact factor: 2.708

8.  Association between hyperlipidemia and mortality after incident acute myocardial infarction or acute decompensated heart failure: a propensity score matched cohort study and a meta-analysis.

Authors:  Mohammed Yousufuddin; Paul Y Takahashi; Brittny Major; Eimad Ahmmad; Hossam Al-Zubi; Jessica Peters; Taylor Doyle; Kelsey Jensen; Ruaa Y Al Ward; Umesh Sharma; Ashok Seshadri; Zhen Wang; Vinaya Simha; M Hassan Murad
Journal:  BMJ Open       Date:  2019-12-15       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.